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Crystallographic snapshots of 
ligand binding to hexameric purine 
nucleoside phosphorylase and 
kinetic studies give insight into the 
mechanism of catalysis
Zoran Štefanić  1, Marta Narczyk2, Goran Mikleušević1, Saša Kazazić1, Agnieszka Bzowska2 & 
Marija Luić1
Purine nucleoside phosphorylase (PNP) catalyses the cleavage of the glycosidic bond of purine 
nucleosides using phosphate instead of water as a second substrate. PNP from Escherichia coli is a 
homohexamer, build as a trimer of dimers, and each subunit can be in two conformations, open or 
closed. This conformational change is induced by the presence of phosphate substrate, and very likely 
a required step for the catalysis. Closing one active site strongly affects the others, by a yet unclear 
mechanism and order of events. Kinetic and ligand binding studies show strong negative cooperativity 
between subunits. Here, for the first time, we managed to monitor the sequence of nucleoside binding 
to individual subunits in the crystal structures of the wild-type enzyme, showing that first the closed 
sites, not the open ones, are occupied by the nucleoside. However, two mutations within the active site, 
Asp204Ala/Arg217Ala, are enough not only to significantly reduce the effectiveness of the enzyme, but 
also reverse the sequence of the nucleoside binding. In the mutant the open sites, neighbours in a dimer 
of those in the closed conformation, are occupied as first. This demonstrates how important for the 
effective catalysis of Escherichia coli PNP is proper subunit cooperation.
Purine nucleoside phosphorylase (PNP, purine nucleoside orthophosphate ribosyl transferase, EC 2.4.2.1) 
has a crucial role in the purine salvage pathway1. It catalyses the reversible phosphorolytic cleavage of the gly-
cosidic bond of purine (2′-deoxy) nucleosides, generating the corresponding free base and (2′-deoxy) ribose 
1-phosphate1,2. The biologically active form of this enzyme, with only one known exception - PNP from Thermus 
thermophilus HB273, is always oligomeric: homotrimers are characteristic mostly for mammals, while homohex-
amers are typical for most bacteria. The arrangement of subunits in the structure of a PNP hexamer is such that 
two of them donate two amino acids (His4 and Arg43 in E. coli) to each other, thus completing the active site of its 
neighbour, effectively forming a dimer which possesses an approximate 2-fold symmetry. Three such dimers are 
then arranged by a 3-fold symmetry axis to form a hexamer.
The molecular mechanism by which this enzyme accomplishes its biological function is particularly intricate. 
In addition to the phosphorolysis being a two-substrate and two-product reversible reaction, with communica-
tion between monomers forming a dimer1, the mechanism is further complicated by the higher order commu-
nication, i.e. an allosteric cross-talk between dimers forming the hexamer4,5. The way in which this allosteric 
communication is achieved is still unclear, but the complexity is reflected in an ever increasing number of differ-
ent arrangements of active site conformations between monomers in the available crystal structures of hexameric 
PNPs6.
The catalytic mechanism of PNP, especially that of E. coli PNP, has been in the focus of our study for many 
years2,5,7–16. It has been firmly established5,14 that the initial step in the catalysis involves breaking a single α-helix 
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H8 (214–236) into two segments (Fig. 1). One of the segments (residues 214–219) moves in the direction of the 
binding pocket, helped by the formation of a γ-turn by the residues 220–222, thus partially closing the active site. 
The remaining part of the H8 α-helix stays in place (residues 223–236). The movement of the segmented part 
of the H8 α-helix is essential as it brings the side chain of the conserved amino acid Arg217 within a hydrogen 
bonding distance to the also conserved Asp204 residue as the initial step in the catalysis5. This triggers the proton 
transfer from Asp204 side-chain, which is initially in the acidic form, to the purine base at the N7 position. The 
crystal structure of the E. coli enzyme, which served for the formulation of the above mechanism5, was the first 
to capture the coexistence of the two conformations of the active site, open and closed, in the hexameric PNPs.
The active site in closed conformation was supposed to bind more strongly both PNP substrates, phosphate 
and nucleoside, than the active site in open conformation. It was proposed that the initial binding and proper 
alignment of the substrates occurs in the open conformation, while catalytic action requires the conformation to 
be closed5. Three different methods were used to validate this model: site-directed mutagenesis, kinetic studies, 
and X-ray crystallography14. These experiments supported earlier predictions that the binding of phosphate and 
its interaction with Arg24 are necessary for the conformational change to occur. Namely, the crystal structure of 
the binary complex of Arg24Ala mutant with the phosphate showed that all six active sites remained in the open 
conformation, indicating that the binding of phosphate in the absence of Arg24 is not sufficient for a conforma-
tional change to take place.
Solution studies have shown that E. coli PNP exhibits the negative cooperativity in binding of substrates and 
their analogues: for example phosphate17 and two non-cleavable analogues of adenosine, formycin A (FA, see 
Fig. 1, right) and its methylated form. Formycins are strong inhibitors of hexameric PNPs5,10,18. Although sto-
ichiometry of stronger and weaker binding sites, as well as weaker binding constants, were not unequivocally 
determined for them, it was shown without any doubt that only part of the sites bind phosphate, FA and their 
analogues, with micromolar dissociation constants and makes the binding to the remaining active sites less 
likely5,10,14,17,18. However, in crystal structures of ternary complexes reported up to now5,13,19, it has never been 
observed that only part of the active sites were occupied by nucleosides.
Here we present a study regarding the wild type enzyme and another active site mutant, double mutant 
Asp204Ala/Arg217Ala (DM), showing how markedly these two mutations can change the binding and catalytic 
properties of PNP. As already mentioned, amino acids Asp204 and Arg217 are responsible for the protonation 
of the nucleoside substrate. Mutation of one or both of these residues markedly lowered the activity of PNP vs. 
natural substrates14, showing that they cooperate mutually in the protonation of the purine base, in agreement 
with the mechanism we proposed previously5.
Detailed study of kinetics of DM versus natural substrate, adenosine, and guanosine analogue, which bears 
a methyl group in the N7 position, introducing a positive charge on the five-membered ring of purine (Fig. 1) 
and therefore not requiring protonation, revealed an unexpected behaviour. Namely, the kinetics with phosphate 
(Pi) as the variable substrate, in case of both proteins, is best described with the same model, allosteric with 
negative cooperativity. But in the case of catalysis with nucleoside as the variable substrate, we observe not only 
different kinetic constants for both enzyme forms, but also the model describing the catalysis changes from the 
Figure 1. Left panel: Open and closed conformation of E. coli PNP. Monomers (A) (green) and (B) (magenta) 
of the wild-type E. coli ternary complex with phosphate/sulphate and FA structure, WT-6(P/S)-6FA, are 
overlapped to show the difference between closed and open active site conformation. The positions of catalytic 
amino acids Asp204 and Arg217 mutated to Ala in the double mutant structures are shown. The extent of 
movement of the loop and segmentation of the helix H8 is indicated by arrows. Right panel: structure of PNP 
ligands used in this study, PNP inhibitor FA, the N9 deaza analogue of the natural enzyme substrate adenosine, 
and 7-methylguanosine, the substrate bearing the positive charge on the five-membered ring of purine as the 
result of methylation at position N7.
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Michaelis-Menten for WT to allosteric with probably positive cooperation for DM mutant. In this work we pres-
ent these findings, and solution and crystallographic studies that explain why these two enzyme forms exhibit 
such striking differences.
Results and Discussion
Kinetic properties of WT and DM. Catalytic and kinetic properties of the wild-type (WT) and the 
Asp204Ala/Arg217Ala double mutant (DM) were studied with adenosine (Ado), which is a natural substrate, 
and 7-methylguanosine (m7Guo), which has a methyl group in the N7 position of the purine that is protonated by 
the enzyme, according to the mechanism proposed5 and verified by studying the active-site mutants14. As a result 
of methylation, m7Guo bears a positive charge on the purine ring (Fig. 1), hence its protonation by the enzyme is 
not necessary. The kinetic data obtained are summarized in Table 1 and depicted in Fig. 2.
Literature data report that E. coli PNP phosphorolysis studied with phosphate as the variable substrate does 
not proceed according to the Michaelis-Menten model14,20. It is rather described by the model of allosteric inter-
action between active sites as a result of binding phosphate (equations (1 and 2), Materials and methods), with 
both sites exhibiting similar maximal velocities, Vmax1 ~ Vmax2, but with the second site characterized by a higher 
Michaelis constant than the first one, Km2 > Km1, hence with negative cooperation between two active sites.
The same phenomenon, i.e. non-Michaelis-Menten kinetics, is observed now for the phosphorolysis of Ado 
and m7Guo catalysed by DM (Table 1), despite the fact that catalytic efficiency vs. these substrates of WT and DM 
enzymes are very different. DM is not able to protonate Ado, hence its catalytic activity (maximal activity of the 
enzyme in the allosteric model used is 2Vmax2) is about 400-fold lower than that of WT (0.05 U mg−1 and 19.3 U 
mg−1, respectively). By contrast, the activity of DM vs. m7Guo is 5 times higher than that of WT (44.2 U mg−1 as 
compared to 8.2 U mg−1). As mentioned above, m7Guo carries a methyl group at position N7 of purine base. Such 
methylation changes charge distribution over purine ring (See Fig. 1) making it imitate the charge distribution of 
protonated Ado, Ino or Guo, a natural substrates, which normally, under pH around 7 are in neutral form. Hence, 
this particular substrate does not require protonation by the enzyme, and it seems logical, that mutation of two 
amino acids responsible for protonation, Asp204 and Arg217 into Ala, has even beneficial effect on the catalysis 
of m7Guo.
Because non-Michaelis-Menten kinetics, is observed for the phosphorolysis of Ado and m7Guo catalysed by 
both enzyme forms, we may conclude that the mechanism of interaction with phosphate is the same for WT and 
DM, in agreement with the fact that only nucleoside-binding site amino acids were mutated in DM.
The situation is completely different when we consider catalysis with nucleoside as the variable substrate 
(Fig. 2 and Table 1). When phosphate is at a constant and saturating concentration, the catalysis conducted by 
the WT enzyme (Fig. 2A) is sufficiently well described by the classical Michaelis-Menten equation. This suggests 
that in such optimal conditions the interaction between subunits is effective and very well synchronized. Catalysis 
Enzyme
Nucleoside as 
constant substrate Km1 [mM] Vmax1 [U mg−1] Km2 [mM]b Vmax2 [U mg−1] a b
Phosphate as variable substrate
Non-recombinanta m7Guo 0.015 ± 0.002 16 ± 1 0.135 ± 0.045 11 ± 1 9 0.69
WT m7Guo 0.015 ± 0.004 10.8 ± 0.7 4.0 ± 3.7 8.2 ± 0.6 267 ± 232 0.76 ± 0.06
DM m7Guo 0.066 ± 0.014 32.5 ± 2.0 6.8 ± 1.9 44.2 ± 2.3 103 ± 26 1.4 ± 0.1
WT Ado 0.23 ± 0.10 20.8 ± 3.6 3.6 ± 2.6 19.3 ± 0.9 15.9 ± 8.2 0.93 ± 0.14
DM Ado 0.28 ± 0.17 0.021 ± 0.006 15.2 ± 8.3 0.050 ± 0.009 55 ± 29 2.4 ± 0.5
Enzyme
Phosphate as 
constant substrate Km1 [mM] Vmax1 [U mg−1] Km2 [mM]b Vmax2 [U mg−1] a b
Nucleoside as variable substrate
Non-recombinantb,c m7Guo 0.036 ± 0.006 30.2 ± 1.7 c c c c
WTc m7Guo 0.027 + 0.002 22.7 ± 0.3 c c c c
DMd m7Guo ~0.110e ~18e 0.024 ± 0.008 29.2 ± 1.5 0.22 ± 0.20 ~1.5e
WTc Ado 0.028 ± 0.004 51.1 ± 2.3 c c c c
DMd Ado 0.013 ± 0.009 0.011 ± 0.025 0.005 ± 0.007 0.043 ± 0.020 0.38 ± 0.24 ∼4.0e 
Table 1. Kinetic parameters fitted to initial velocity data obtained at pH 7.0, 50 mM Hepes buffer, 25 °C for WT 
and DM mutant of E. coli PNP with (upper part) phosphate as the variable substrate (Ado at 0.22 mM or m7Guo 
0.25 mM), and (lower part) nucleoside as the variable substrate (phosphate at 50 mM); using allosteric interaction 
site model (equations (1, 2)). Errors of the parameters determined in this study are fitting errors. Parameters 
Km1 and Vmax1 are apparent Michaelis constant and apparent maximal velocity observed with one site occupied 
by the variable substrate, and with the neighbouring site free, while Km2 = aKm1 and Vmax2 = bVmax1 characterise 
one site when the neighbouring site is occupied. In most cases, the kinetic parameters shown in the table are an 
average from several independent experiments. aFrom Modrak-Wójcik et al.20. bFrom Bzowska et al.9. cMichaelis-
Menten model was sufficient to describe the kinetic data in this case. dThe kinetic model for the nucleoside as 
variable substrate may be even more complicated, since for some data sets several minima with very similar sum 
of squares were found. The most important finding for the purpose of this report is that, in contrast to WT, the 
Michaelis-Menten model was not sufficient to describe the initial velocity kinetic data for DM and nucleoside as 
variable substrate. eErrors are high, >50%, so a more precise value of the parameter could not be given.
www.nature.com/scientificreports/
4Scientific REPORTS |  (2018) 8:15427  | DOI:10.1038/s41598-018-33723-1
occurs only in the closed sites, but phosphate is bound also to the neighbouring open site of the same dimer. In 
this way, the presence of two kinds of sites is not reflected in the kinetics of the reaction.
This is not the case with DM (Fig. 2B), for which Michaelis-Menten model is not sufficient to describe the 
kinetic data when nucleoside is the variable substrate, and the interacting sites model seems to be more appropri-
ate. However, as opposed to the kinetics when phosphate is the variable substrate, in this case there is an indica-
tion that Km2 might be lower than Km1 (however errors are too big to unequivocally show it, see Table 1). It means 
that the site, which is occupied at a higher nucleoside concentration, might have a lower Michaelis constant, 
suggesting a possible positive cooperation between active sites of DM.
These findings prompted us to conduct further studies aimed at understanding how these two mutations affect 
the mechanism of catalysis and/or binding of ligands.
Differential analysis of amide hydrogen/deuterium exchange for WT and DM. As shown pre-
viously19 for E. coli PNP, in the WT enzyme hydrogen/deuterium exchange rate is changing markedly upon 
the binding of ligands, and mutants can behave differently than the WT. A comparison of hydrogen/deute-
rium exchange data collected for WT and DM PNPs allowed us to detect differences in the flexibility of these 
two enzymes in the apo form, in binary complexes with phosphate (Pi), and in ternary complexes with phos-
phate, and the non-cleavable analogue of adenosine, formycin A (FA, see Fig. 1, right), which, as mentioned 
in the Introduction, is a strong inhibitor of hexameric PNPs5,10,18. A difference in deuterium uptake between 
the three states of two protein forms (Fig. 3) is found just in two peptide fragments, p22 and p23, both hold-
ing a mutation site (Asp204Ala and Arg217Ala) and covering sequence regions of the WT E. coli PNP 
202VSDHIRTHEQTTAAE216 for p22 and 217RQTTFNDM224 for p23. In all other fragments, changes induced 
by phosphate and FA binding are the same for both enzyme forms, WT4 and DM. Namely, phosphate binding 
induces a significant reduction in the conformational dynamics of the binary complex in those structure regions 
that contain amino acid residues establishing strong H-bonds with Pi in the active site. Phosphate forms strong 
hydrogen bonds with Arg24, Arg87, Arg43 (the last one form neighbouring monomer of the same dimer) and 
Ser90. In the closed active site of the WT, Arg217 and Asp204 are H-bonded between each other, while in the 
open conformation Pi makes H-bonds with Ser203 (p22) and - in WT only - with Arg217 (p23), that do not exist 
in the closed conformation. Exchange kinetics of peptides 22 and 23 is fast, and a dynamics slowdown upon Pi 
binding is visible only during the shortest time period of 10 seconds.
Differences detected in structure flexibility between WT and DM double mutant can be seen in fragments 
22 (Fig. 3A, left) and 23 (Fig. 3A, right) because both peptides contain alanine (A) residues instead of charged 
aspartic acid (Asp, peptide 22) and charged arginine (Arg, peptide 23). Relative to the unliganded state (Fig. 3B, 
Figure 2. Activity of E. coli PNP and its DM mutant, with nucleoside, Ado (□) and m7Guo (■), as variable 
substrates, and a constant, saturating concentration of the second substrate, phosphate. The reactions were 
conducted at 25 °C in 50 mM Hepes buffer at pH 7.0 and followed by direct spectrophotometric assays. Fitting 
was performed with the equation (1), representing allosteric interaction between binding sites (solid lines) 
and with the Michaelis-Menten (MM) equation (dashed lines). For WT enzyme (A), MM equation described 
the data properly, while for DM (B) and data sets shown here F-test indicated that equation (1) was more 
appropriate (see also Materials and Methods). Error bars represent a standard deviation of the average rate 
from several independent measurements. For the DM and m7Guo as variable substrate averaging of rates lead 
to high errors of fitted parameters therefore fitting was performed separately for each experiment and one such 
experiment is depicted on this figure. Kinetic parameters obtained from the fitting of MM and (1) equations, for 
WT and DM, respectively, are shown in Table 1.
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black line, right), at 10 s, the double mutant shows a higher deuterium uptake upon Pi binding for fragment 23 
(Fig. 3B, red line, right). This is opposite to a decrease in deuterium uptake (Fig. 3A, red line, right) observed for 
WT fragment 23 at the same exchange time period. Due to the absence of Arg217, in DM the Pi charge cannot 
be neutralized as effectively as in the WT form, thus allowing water molecules to enter into the active site cavity 
and increase deuterium uptake relative to the unliganded form, as shown in Fig. 3. Structure region of the double 
mutant covered by peptide 22 is placed out of the active site cavity so that Pi charge solvation (Fig. 3B, red line, 
left) does not change deuterium uptake in this region relative to the unliganded form (Fig. 3B, black line, left).
After FA binding, the ribose part of the molecule establishes H-bonds with the side chain of Glu181, fixing 
motion of that part of the protein structure and causing a lower deuterium uptake for peptide 19 in both enzyme 
forms, WT4 and DM (not shown).
Differences in the conformational flexibility of WT and DM induced by FA binding can be observed again, 
like in the case of enzyme/Pi binary complex, for p22 and p23. All graphs show an increased deuterium uptake 
upon FA binding to the active site (blue line over red line) because hydrogen bonding rearrangement caused by 
the binding of this bulky molecule relaxes the overall structure rigidity obtained after entering Pi into the active 
site. Deuterium uptake for the ternary complex of the WT remains lower for p22 (Fig. 3A, blue line, left) or the 
same for p23 (Fig. 3A, blue line, right) as the uptake values for the unliganded form (Fig. 3A, black lines, left and 
right), but it is higher than the uptake measured for both peptides in the binary complex with phosphate (Fig. 3A, 
red lines, left and right). For the double mutant, deuterium uptake values are always higher for the ternary com-
plex (Fig. 3B, blue lines, left and right) relative to either the unliganded form (Fig. 3B, black lines, left and right) or 
the binary complex with phosphate (Fig. 3B, red lines, left and right), indicating that the conformational flexibility 
arrest caused by Pi binding is not that pronounced in the double mutant as it is in the wild-type hexamer.
Overall protein structures. We have then conducted crystallographic studies to check whether a lack of 
two charged amino acids in the E. coli PNP active site can influence the conformations of the terminal α-helix, 
namely whether it can hamper segmenting this helix and closing active sites and whether this was an explanation 
of the above-described kinetic and hydrogen/deuterium exchange experiments. As a nucleoside, the same as in 
solution studies, FA, a non-cleavable structural analogue of the natural substrate adenosine was used (Fig. 1). It 
turned out that the conformation of both proteins with all the active sites occupied by both ligands was the same, 
with a closed conformation in one of three active sites (Fig. 4). Both ligands are in the same orientation in the 
active sites of WT and DM, and the conformation of crucial amino acids is very similar. This suggests that the 
differences introduced by these two mutations within the active sites and cooperation of the active sites within 
Figure 3. Deuterium uptake curve for unliganded protein (black trace), phosphate complex (red trace) 
and complex with phosphate and FA (blue trace). Each deuterium incorporation point is an average of 3 
independent experiments. Analysis of the standard deviation for all triplicates provided a 98% confidence 
interval of about ±0.3 Da. Error bars were marked in the figure but are too small to be clearly visible. Deuterium 
incorporation graphs for (A) peptides 202–216 VSDHIRTHEQTTAAE and 217–224 RQTTFNDM of the wild-
type E. coli PNP and (B) peptides 202–216 VSAHIRTHEQTTAAE and 217–224 AQTTFNDM of the E. coli 
PNP Asp204Ala/Arg217Ala mutant.
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a hexamer are not assessable by the standard X-ray crystallographic experiments in which we are able to see the 
final effect of the ligand binding process, but not how the process proceeds.
We have made attempts to crystallise PNP in such a way to obtain structures with not all active sites filled 
with a nucleoside FA. The first attempt was to crystallise the protein with Pi only and to soak crystals for a short 
period of time in FA solution at various and decreasing concentrations of the nucleoside. Each time the structures 
obtained by this method contained FA molecules in each active site, though not always at full occupancy. Despite 
many trials and various FA concentrations in the soaking solutions, these results were the same.
Therefore, we tried another approach: setting crystals of ternary complexes, prepared at different FA to PNP/Pi 
complex concentration ratios. As a result of such co-crystallisation experiment, structures with part-of-the-sites 
occupancy of FA were finally obtained.
All PNP structures determined in this study show a homohexamer consisting of six chains of identical 
sequences of 238 amino acids (Fig. 4). They can be considered as trimers of dimers possessing approximately 
32 point group symmetry. In the case of orthorhombic structures of the wild-type enzyme with two formycin 
molecules (WT-6(P/S)-2FA) and of the double mutant complexes with two and four formycin molecules per 
hexamer bound, (DM-6(P/S)-2FA and DM-6(P/S)-4FA, respectively) all six monomers are crystallographically 
independent, whereas in the case of hexagonal structures of the wild-type and the mutant with six formycin mole-
cules bound by each hexamer (WT-6(P/S)-6FA and DM-6(P/S)-6FA) two halves of the hexamer are related by the 
crystallographic two-fold axis. As already observed for WT/Pi binary complex14, and WT ternary complexes with 
phosphate (sulphate) and FA15, and also FA derivatives5, each monomer can be found in either open or closed 
active site conformation (Fig. 1). In the active site pocket, phosphate and nucleoside binding sites can be distin-
guished. All phosphate binding sites of here described ternary complexes, both wild-type and double mutant, are 
occupied by phosphate or sulphate (precipitating agent in crystallisation). The collected experimental data for all 
five presented crystal structures do not allow a distinction between phosphate and sulphate ions, but in view of all 
the previous results14,17, phosphate ions are present in active sites in the closed conformation.
Occupancy of the FA ligands. Difference electron density maps of the two wild-type structures are shown 
in Fig. 5, while those of the three double-mutant structures are shown in Fig. 6. Maps are omit maps calculated 
without water and FA molecules in the active site. Maximum likelihood 2mFo-DFc maps are contoured at level 
1σ, while mFo-DFc difference maps are contoured at levels 3σ and -3σ. Estimating the occupancy of ligands in 
the active sites of the proteins only by crystallographic measurements is problematic at best21,22, therefore special 
attention was paid not to bias the analysis (see Materials and methods)21,22.
All of the structures have two monomers in closed conformations (A and F) next to each other but belonging 
to two different dimers, and four monomers in open conformations (B, C, D and E). In the orthorhombic struc-
tures, dimers A-D and F-C are closed-open dimers and B-E form an open-open dimer, while in the hexagonal 
Figure 4. Schematic drawing of the hexamers of PNP in the two space groups. The colours indicate open 
(green) and closed (blue) conformations of monomers’ active sites. The amino acids of helix H8 (214–219) 
that move during the change of active sites’ conformation are shown in red. Arrows show which chains join 
together to form a dimer. (A) In the case of orthorhombic structures WT-6(P/S)-2FA, DM-6(P/S)-2FA and 
DM-6(P/S)-4FA, chains A and F are in closed conformation and chains B, C, D and E are in open conformation. 
(B) In the case of hexagonal structures WT-6(P/S)-6FA and DM-6(P/S)-6FA, only one half of the hexamer is 
crystallographically independent and the other half is generated by crystallographic two-fold axes (indicated by 
the paler half). In terms of open and closed conformations, in structures WT-6(P/S)-6FA and DM-6(P/S)-6FA, 
chain A (and by symmetry also A’) is in closed conformation, while B and D (and their symmetry equivalents B’ 
and D’) are in open conformation.
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forms A-D is the closed-open dimer and B-B’ is the open-open dimer formed by crystallographic two-fold sym-
metry (Fig. 4).
In the structure of WT-6(P/S)-2FA, the FA molecules are found only in the closed active sites A and F with 
final occupancies of 0.7 (Fig. 5A, Table 2). All of the active sites in the open conformation in this complex are 
occupied only by water molecules. This is the first time that the presence of nucleoside type substrate only in the 
active sites in closed conformations was shown. This strongly indicates a higher affinity of these sites for nucle-
osides in comparison with active sites in the open conformation and confirms our conclusion based on solution 
studies5, namely that negative cooperativity is also present in the binding of the nucleoside substrate.
The crystal structure of complex WT-6(P/S)-6FA was obtained with a higher concentration of FA compared to 
structure WT-6(P/S)-2FA, and this resulted in filling all the active sites, including those in the open conformation 
(Fig. 5B, Table 2). Difference electron density for omitted FA is best in the closed active site A, then in the open 
active site B, and finally somewhat poorer in the open active site D, which forms an open-closed dimer with site 
A. This is backed up by the values of occupancies of FA molecules, which in these three active sites are given as 
A:B:D = 0.8:0.5:0.4. This suggests that in the wild-type enzyme the active site B from the open-open B-B’ dimer 
exhibits a slightly higher affinity towards FA than the active site D that belongs to the closed-open A-D dimer 
(Fig. 5B).
The occupancies of FA molecules show a significantly different behaviour in the structures of the double 
mutant. Although the active sites A and F are closed in the structure of DM-6(P/S)-2FA, these sites are not first 
occupied by FA molecules. The only active sites that are occupied with FA molecules in structure DM-6(P/S)-2FA 
are open active sites D and C (Fig. 6A) from the closed-open dimer. Occupancy factor for both FA molecules in 
these active sites is 0.7. Closed active sites A and F and open active sites B and E are filled with water molecules 
only. The order of filling the active sites has changed with respect to the wild-type enzyme. It is evident that 
changing the two most important amino acids from the nucleoside binding site, Asp204 and Arg217, completely 
changed the affinity and probably cooperativity of the subunits (which is reflected in the kinetic properties, as 
discussed above). This demonstrates how only a few mutations of catalytically important amino acids can change 
the whole molecular mechanism of enzyme action.
When we used a higher concentration of FA molecules in the preparation of the ternary complex of the 
mutated protein, structure DM-6(P/S)-4FA, the FA molecules entered the closed active sites (Table 2). Here the 
occupancies of FA molecules are the same in closed sites A and F and in D and C, namely 0.6, and a visual 
Figure 5. Electron density maps of the active site of the wild-type structures (A) WT-6(P/S)-2FA and (B) 
WT-6(P/S)-6FA given in approximately equal orientations. Maps shown are omit maps where the water and 
FA molecules in the active sites were omitted from the refinement (i.e. their occupancy was set to 0 and their 
coordinates were fixed). Maximum likelihood mFo-DFc difference maps contoured at levels 3σ and -3σ are 
given in green and red, respectively. (A) In the case of structure WT-6(P/S)-2FA, chains A and F are in closed 
conformation and the presence of difference electron density indicates the presence of FA molecules in the 
active site. The remaining four chains (B–E) are in open conformation, and no continuous density could be 
identified where FA molecules could be placed. (B) Higher concentration of FA in the structure WT-6(P/S)-
6FA results in filling the active sites of all the chains. Here also only chains A and F are in closed conformations. 
Difference electron density around FA molecule in chain D is slightly less noticeable than in the other open site 
B, probably indicating a lower binding affinity.
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inspection of difference electron density justifies this (Fig. 5B). The active sites of open-open dimer B-E are with-
out FA molecules; instead the active site binds water molecules. This structure shows the second step in the filling 
of the active sites: after the open sites from the open-closed dimer, the closed sites from the same dimer show the 
highest affinity for FA.
Finally, with the highest concentrations of FA used in preparing the complexes, all the sites become occupied 
with FA molecules, as demonstrated by the electron density in structure DM-6(P/S)-6FA (Fig. 6C). Here all the 
Figure 6. Electron density maps of the active sites of the double mutant crystal structures DM-6(P/S)-2FA, 
DM-6(P/S)-4FA and DM-6(P/S)-6FA given in approximately equal orientations. Maps shown are omit maps 
where the water and FA molecules in the active sites were omitted from the refinement (i.e. their occupancy 
was set to 0 and their coordinates were fixed). Maximum likelihood mFo-DFc difference maps contoured at 
levels 3σ and -3σ are given in green and red, respectively. (A) In the structure DM-6(P/S)-2FA, the FA electron 
density is most pronounced in chains C and D and it clearly shows the presence of FA ligands. This is in marked 
contrast to chains A and F, which are in the usual closed conformation, but with electron density in the form 
of separate blobs, which are modelled as water molecules. Electron density is poorest in the open-open dimer 
B-E and is modelled as separate water molecules. (B) In the structure DM-6(P/S)-4FA, electron density around 
FA molecules is still most prominent in the open sites C and D, but this time also shows the presence of FA 
molecules in the corresponding closed chains A and F. Open-open dimer B-E remains occupied by water 
molecules only. (C) The concentration of FA molecules in the structure DM-6(P/S)-6FA is such to allow all 
active sites to be occupied and the electron density is clearly present in all six active sites of the hexamer (the 
other half of the molecule is symmetrically equivalent).
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sites clearly show the presence of the nucleoside and the refined occupancies of FA molecules are 0.7, 0.5, and 0.6 
for chains A, B, and D, respectively. This is the third step in the process of FA binding to the E. coli PNP double 
mutant, which we could clearly identify by the X-ray crystallography method.
Insight into the mechanism of catalysis. E. coli PNP is an excellent molecular machine conducting effi-
cient catalysis of purine nucleosides glycosidic bond cleavage. As described above it is a homohexamer, built as a 
trimer of dimers, with all its subunits having the active site in the open conformation in the apo enzyme form23. 
Monomers in each dimer mutually donate two amino acids (His4 and Arg43) to complete their active sites. Thus, 
dimers in principle have all the features necessary to work independently. However, as we have shown recently, 
a trimer-of-dimers architecture is necessary to stabilize the three-dimensional structure of dimers and preserve 
their ability to form a closed conformation of the active site16. This in turn enables proper interactions of the 
enzyme with the nucleoside, and its protonation at position N7 of the purine base, which is a prerequisite for an 
efficient catalysis5. Here we take a step forward in understanding the molecular mechanism of this complicated 
catalyst by presenting crystallographic snapshots of ligand binding to individual subunits of the hexamer, WT 
enzyme and its DM - with mutations of two crucial amino acids responsible for the protonation of the nucleo-
side. We show that the sequence of events derived from X-ray structure is different in these two enzyme forms, 
and these results correlate well with the catalytic and kinetic properties of WT and DM. In the case of WT, at 
low nucleoside concentrations, the nucleoside is bound mostly in sites adopting a closed conformation, which 
facilitates protonation, hence also catalysis. In the case of DM, which is not able to protonate the substrate inde-
pendently of active site conformation, as Asp204 residue is missing in this enzyme form (replaced by Ala), the 
nucleoside is bound mostly in active sites adopting the open conformation. However, m7Guo due to the methyl 
group at position N7 of the purine base, imitating protonation, already bears the positive charge. Therefore its 
further protonation by the enzyme, and the conformational change i.e. active site closing, enabling protonation, 
seems not just unnecessary, but are probably not even desirable, making additional, in this case not required, step 
in the catalytic cycle. And indeed, in the structure of the DM enzyme, active sites in the closed conformation are 
not the ones that are occupied first by nucleoside - open sites are those that bind nucleoside in the beginning. 
This change of nucleoside binding sequence by individual subunits makes DM an excellent catalyst, even better 
than the WT PNP, towards m7Guo. These results also show that residues Asp 204 and Arg 217 are responsible not 
only for protonation of the nucleoside but also influence the way how subunits of the enzyme cooperate with each 
other to conduct the efficient catalysis.
To the best of our knowledge, this is the first case reported in the literature where the sequence of ligand 
binding events at the active sites of the oligomeric enzyme (which also explains important catalytic properties of 
this molecule) was followed by crystallographic occupancy refinement of the series of enzyme-ligand complexes 
obtained by a step-wise slow increase of the ligand to protein concentration ratio in a co-crystallisation experi-
ment, thus managing to fill two, four or all six active sites of the enzyme. This shows that a similar approach can 
also be used to follow ligand binding steps for other homooligomeric proteins showing negative cooperation 
between active sites, especially the so-called part-of-the-sites binding enzymes24.
Materials and Methods
Kinetic methods. All kinetic data were obtained as described previously14. Direct spectrophotomet-
ric method was used to follow phosphorolysis in 50 mM Hepes buffer pH 7.0, at 25°C of Ado (λobs = 265 nm, 
Δε  = −1690 M−1cm−1) and m7Guo (λobs = 260 nm, Δε  = −4600 M−1cm−1). Cuvettes with 1, 0.5, 0.2 and 0.1 cm 
path length were used to cover a broad nucleoside concentration range. Either the classical Michaelis-Menten 
model or the interacting site model was fitted (two equivalent forms used in literature are shown)20,25:
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WT-6(P/S)−2FA WT-6(P/S)-6FA DM-6(P/S)-2FA DM-6(P/S)-4FA DM-6(P/S)-6FA
Location of FA molecules and occupancy factors
Molar ration PNP:FA 1:0.14 1:0.57 1:0.4 1:0.6 1:1.2
Space group P 21 21 21 P 61 2 2 P 21 21 21 P 21 21 21 P 61 2 2
Monomers in the asymmetric unit A, B, C, D, E, F A, D, B A, B, C, D, E, F A, B, C, D, E, F A, D, B
Dimers A-D; F-C; B-E A-D; A’-D’; B-B’ A-D; F-C; B-E A-D; F-C; B-E A-D; A’-D’; B-B’
Occupancy factor in: A,F - closed 
sites 0.7; 0.7 0.8 no FA 0.6; 0.6 0.7
Occupancy factor in: D,C - open 
sites in the closed-open dimer no FA 0.5 0.7; 0.7 0.6; 0.6 0.5
Occupancy factor in: B,E or B,B’ - 
open sites in the open-open dimer no FA 0.4 no FA no FA 0.6
Table 2. Location of FA molecules in the closed and open active sites of the E. coli PNP wild-type and double 
mutant hexamers (trimer of dimers), occupancy factors of FA molecules in the individual active sites (See also 
Figs 5 and 6), and data collection and refinement statistics.
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Km1 and Vmax1 are apparent Michaelis constant and apparent maximal velocity, respectively, observed when the 
neighbouring site is free; aKm1 =Km2 and bVmax1 = Vmax2 characterise one site when both sites are occupied; c0 
refers to the concentration of the variable substrate; and fitted parameters depend, in general, on the concentra-
tion of the co-substrate, which is held constant. The highest velocity observed at saturating concentration of the 
variable substrate is 2Vmax2.
Curve-fitting was carried out by the GraphPad Prism program (Intuitive Software for Science, San Diego, 
CA, USA). The more complicated model (Equations (1, 2)) was chosen if there was a statistically significant 
decrease in the sum of residuals as judged by the F-test at 95% confidence level. Phosphorolysis was measured 
several times for the same substrate concentration, and weights 1/SD2, where SD is a standard deviation of the 
average rate, were used in fitting. Since rates for high nucleoside concentration measured in thin cuvettes (0.2 
and 0.1 cm) are prone to high error, in many cases weighting led to a different conclusion regarding the correct 
kinetic model when compared with the results of the cases in which no weights were used. With phosphate as the 
variable substrate, there was never any doubt that the interacting sites model described the data better, while with 
a nucleoside as the variable substrate, the result depends on the range of substrate concentration employed and on 
the weighting method used. For data sets shown in Fig. 1, for DM (right panel), F value is 14.2 and 8.2 for Ado and 
m7Guo, respectively. This indicates that there is only less than 0.0001% and 0.004% chance, respectively, that the 
data, that are described so much better by the interacting site model than by the Michaelis-Menten model, were 
obtained randomly. However, the kinetic model for of the nucleoside catalysis conducted by DM may be even 
more complicated than the one described by eqs (1, 2), since for some data sets several minima with very similar 
sum of squares were found. The most important finding for the purpose of this report is that, in contrast to WT, 
the Michaelis-Menten model was not sufficient to describe the initial velocity kinetic data for DM with nucleoside 
as the variable substrate (see Results and Discussion).
Hydrogen/deuterium exchange mass spectrometry experiment. All HDX experiments were con-
ducted at room temperature. H/D exchange reaction was initiated by diluting 5 µL of the protein stock solution 
(~75 mM protein concentration in 20 mM Tris-HCl, pH 7.4) in 45 µL of deuterated exchange buffer (20 mM 
Tris-HCl, pH 7.4 in D2O). The kinetics of the H/D exchange reaction was followed by measuring deuterium 
uptake at 5 time points: 10 s, 1 min, 20 min, 1 hour and 4 hours for peptides obtained from the digested pro-
tein. Deuterium exchange reactions were performed in triplicate, and the reported values for every peptide are 
an average of three independent reactions without correcting for back exchange. Statistical analysis was done 
according to Houde et al.26. Observed differences in deuterium incorporation at a particular time period which 
are greater than 0.3 Da are considered as significant. The reactions were quenched by lowering the pHread to 2.5 
and temperature close to 0 °C by adding 10 µL of pre-chilled stop buffer (2 M glycine buffer in D2O, pH 2.5) 
into the reaction solution. The established slow exchanging conditions (pH 2.5 and temperature ~ 0 °C) were 
maintained during 1.5 minutes of protein digestion performed using on-line Waters H/D exchange technology 
platform27 and a pepsin column (Poroszyme cartridge, 2.1 mm diameter and 30 mm length, Applied Biosystems) 
which was kept at room temperature. Trapping flow rate was 200 µL/min. Mass spectral information was col-
lected throughout the peptic fragment elution profile from the reversed phase LC column (Acquity UPLC BEH 
C18 Column, 1.0 × 100 mm, 1.7 mm, Waters). At lowered temperature (~0 °C), the mobile phase composed of 
93% of solvent A (0.1% formic acid in H2O) and 7% of solvent B (0.1% formic acid in acetonitrile) was pushed 
through the UPLC column at 55 µL flow rate while generating back pressure of close to 9000 psi. Gradient elution 
of the peptides was started at the solvent composition of A(93%)/B(7%), and the ratio was continuously changed 
during the following 7 minutes to achieve A(65%)/B(35%) composition. The ratio was rapidly changed during 
the next 50 seconds to reach A(15%)/B(85%) and was held at that level for the next 2.5 minutes. In the final 
chromatography step, during 50 seconds, solvent composition was reverted to A(93%)/B(7%) and retained until 
the end of the 12 minutes long elution. Mass spectra of the eluting peptides were acquired in the mass range of 
300–1500 Da with continuous infusion of 0.5 µM leu-enkephalin solution for internal calibration. Undeuterated 
samples allowed for pepsin-digested peptides list to be assembled by using Waters ProteinLynx Global Server 
(Waters, Milford, MA). The amount of incorporated deuterium for each peptide was determined using Waters 
DynamX 2.0 software package. Differential comparisons of H/D exchange data collected for two protein forms 
(wild-type and Asp204Ala/Arg217Ala mutant of E. coli PNP), each in three states (unliganded, binary complex 
with Pi, and ternary complex with Pi and FA), were carried out according to a procedure described elsewhere28,29.
Preparation of ternary complexes for crystallisation. Recombinant wild-type and double mutant 
PNP proteins were prepared and purified as described previously14. Both proteins were concentrated to millimo-
lar range (3–6 mM) in 10 mM citric buffer pH 7.0. Formycin A (5 mM or 10 mM) solution was prepared in the 
same buffer. As a source of phosphate, a 200 mM sodium phosphate buffer pH 7.0 was used. Ternary complexes 
of both WT and DM were obtained by mixing the appropriate volumes of protein, phosphate and FA solutions 
to reach a certain molar ratio of protein and FA. Phosphate concentration in all complexes was 5.5 times higher 
than protein concentration. The molar ratio between WT and FA in the prepared complexes WT-6(P/S)-2FA 
and WT-6(P/S)-6FA was 1:0.14 and 1:0.57, respectively. In previous studies where full ligand occupancy was 
observed, this ratio was 1:2.55. For DM-6(P/S)-2FA, DM-6(P/S)-4FA, and DM-6(P/S)-6FA molar ratio was 1:0.4, 
1:0.6 and 1:1.2, respectively. FA was added 10 minutes after adding phosphate buffer in all three DM complexes.
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Crystallisation and data collection. All complexes of PNP were crystallised at 18 °C using the 
hanging-drop vapour-diffusion method. All five complexes crystallised in the conditions with 50 mM citric 
buffer pH 5.2 and 32–34% ammonium sulphate (w/v). Crystals appeared after a month and were frozen in liquid 
nitrogen when they stopped growing. Prior to flash-freezing in liquid nitrogen, the crystals were soaked for a 
few seconds in a cryoprotecting solution containing 30% glycerol. In-house single-crystal data from complex 
WT-6(P/S)-2FA were collected on Xcalibur Nova R single-crystal diffractometer at 100 K using Cu Kα radiation 
(1.542 Å) and were processed and scaled using the CrysAlisPro software (Agilent Technologies). Diffraction data 
on complexes WT-6(P/S)-6FA and DM-6(P/S)-2FA were collected on BL14.1 operated by Helmholtz-Zentrum 
Berlin (HZB) at the BESSY II electron storage ring (Berlin-Adlershof, Germany) on a PILATUS 6 M detector 
using 2 s exposure and a single wavelength of 0.978 Å30. The data for complexes DM-6(P/S)-4FA and DM-6(P/
S)-6FA were collected at ESRF BM14 beamline using MAR CCD 225 mm detector and a single wavelength of 
0.954 Å. The data from synchrotron measurements were processed and scaled using the XDS package31. The 
crystals of proteins WT-6(P/S)-2FA, DM-6(P/S)-2FA, and DM-6(P/S)-4FA belonged to the orthorhombic space 
group P 21 21 21 with one hexamer in the asymmetric unit, while the crystals of complexes WT-6(P/S)-6FA and 
DM-6(P/S)-6FA belonged to the hexagonal space group P 61 2 2 with one half of the hexamer in the asymmetric 
unit (Fig. 4). Full data collection, refinement and model statistics are given in Table 3.
Structure determination and refinement. All of the crystal structures were determined and refined 
using the PHENIX suite32. The model for molecular replacement was PNP wild-type5 (PDB: 1K9S). No prior 
information was introduced as to whether the monomers were in closed or open active site conformation because 
the flexible part of the H8 α-helix was removed from the model. Special attention was paid in rebuilding the 
regions that had been excluded from the search model in order to clearly distinguish between open and closed 
active sites using Coot33. Figures of crystallographic structures were prepared in Pymol (The PyMOL Molecular 
Graphics System, Version 1.5.0.4 Schrödinger, LLC). Estimating the occupancy of ligands in the active sites of 
the proteins only by crystallographic measurements is problematic at best21,22. Because occupancy of a ligand is 
strongly correlated with the thermal displacement parameters of individual atoms, special attention was paid to 
taking this into account. In all the active sites, presence of PO4/SO4 molecules was clearly visible so their occu-
pancy was set to 1.0 and their B-factors were refined. As the crystallisation conditions contained sulphate ions, 
and they are crystallographically indistinguishable from phosphate, we have used the formulas PO4/SO4 (P/S) to 
emphasize this. When difference electron density in the active site clearly evidenced the presence of FA molecules, 
they were placed into electron density with the occupancy less than 1.0, and the occupancy was refined while 
B-factors of the ligand atoms were fixed during occupancy refinement. The value at which B-factors of all the 
WT-6(P/S)-2FA WT-6(P/S)-6FA DM-6(P/S)-2FA DM-6(P/S)-4FA DM-6(P/S)-6FA
Data collection
Space group P 21 21 21 P 61 2 2 P 21 21 21 P 21 21 21 P 61 2 2
Cell dimensions
a, b, c (Å)
α, β, γ (°)
61.9, 123.4, 189.0,
90, 90, 90
120.6, 120.6, 240.0,
90, 90, 120
62.7, 123.9, 188.7,
90, 90, 90
61.9, 124.2, 189.4,
90, 90, 90
120.7, 120.7, 239.5,
90, 90, 120
Resolution (Å) 28.6–2.3 (2.4–2.3)* 48.2–1.77 (1.8–1.7) 44.4–2.0 (2.1–2.0) 47.84–1.89 (1.96–1.89)
48.14–1.87 
(1.94–1.87)
Rmeas 0.13 (0.31) 0.09 (0.46) 0.14 (0.48) 0.18 (0.80) 0.35 (0.81)
Rpim 0.07 (0.23) 0.02 (0.11) 0.04 (0.16) 0.07 (0.64) 0.09 (0.23)
CC1/2 0.98 (0.74) 1.00 (0.97) 0.99 (0.94) 0.99 (0.38) 0.99 (0.73)
Mean I/σ(I) 8.7 (2.6) 42.2 (9.6) 16.6 (5.4) 10.9 (1.0) 8.2 (3.3)
Completeness (%) 99.6 (98.0) 97.3 (80.1) 99.5 (98.9) 98.8 (87.9) 99.8 (98.3)
Multiplicity 3.7 (2.3) 39.4 (32.7) 12.8 (13.1) 6.5 (3.6) 19.0 (20.5)
Refinement
Resolution (Å) 28.6–2.3 (2.4–2.3) 48.2–1.77 (1.8–1.7) 44.4–2.0 (2.1–2.0) 47.8–1.9 (1.96–1.89) 48.1–1.9 (1.94–1.87)
No. reflections 241525 (14424) 3871879 1276422 (127853) 757641 (36393) 1617111 (170636)
Rwork/Rfree 0.18/0.24 (0.23/0.31) 0.16/0.18 (0.18/0.21) 0.15/0.20 (0.17/0.24) 0.17/0.21 (0.31/0.34) 0.16/0.19 (0.27/0.32)
Number of atoms 11783 6275 12135 12104 6447
Macromolecules 10910 5485 10716 10726 5512
ligands 68 72 98 131 87
water 805 718 1321 1247 845
Protein residues 1430 711 1414 1414 714
RMSD bonds (Å) 0.008 0.008 0.007 0.008 0.009
RMSD angles (°) 1.11 1.14 1.09 1.11 1.14
Table 3. Data collection and refinement statistics. *Highest resolution shell is shown in parentheses. Notation: 
WT-6(P/S)-2FA - ternary complex of wild-type protein with all 6 active sites in the homohexamer occupied by a 
phosphate/sulphate ion and 2 sites occupied by FA with similar connotations for other occupancies of FA in WT 
and DM ternary complexes.
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atoms were fixed was the average value for that ligand in the previous round of refinement. If electron density was 
not conclusive, both fitting the ligand and the water molecules was tried, and in the end the decision was made by 
a critical assessment of the fit. To estimate the uncertainty of the finally obtained occupancies, many refinement 
rounds with the starting occupancies of FA molecules set to initial random values between 0 and 1 were done. 
The final values of occupancies obtained in this way did not vary more than 0.01, irrespective of the starting occu-
pancy value for all FA ligands in all the structures.
Accession codes. The coordinates and structure factors have been deposited in the PDB (Protein Data Bank) 
with the following codes: 4TS3 for WT-6(P/S)-2FA, 4TS9 for WT-6(P/S)-6FA, 4TTA for DM-6(P/S)-2FA, 4TTI 
for DM-6(P/S)-4FA, and 4TTJ for DM-6(P/S)-6FA complex.
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